Barnes Alane's most recent trade in Biocryst Pharmaceuticals Inc. was a trade of 250,100 Emp. Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 19, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals Inc. | Barnes Alane | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 250,100 | 250,100 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 120,700 | 415,190 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.39 per share. | 19 Dec 2024 | 2,461 | 412,729 (0%) | 0% | 7.4 | 18,187 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.53 per share. | 14 Dec 2024 | 8,613 | 294,490 (0%) | 0% | 7.5 | 64,856 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Purchase of securities on an exchange or from another person at price $ 5.53 per share. | 13 May 2024 | 5,000 | 300,762 (0%) | 0% | 5.5 | 27,650 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.05 per share. | 19 Dec 2023 | 2,482 | 293,539 (0%) | 0% | 6.0 | 15,016 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Barnes Alane | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 158,500 | 158,500 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 64,000 | 300,036 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.43 per share. | 14 Dec 2023 | 4,015 | 296,021 (0%) | 0% | 6.4 | 25,816 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2022 | 158,500 | 158,500 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2022 | 34,000 | 232,770 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 10.88 per share. | 15 Dec 2022 | 4,175 | 198,770 (0%) | 0% | 10.9 | 45,424 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 164,000 | 164,000 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 75,000 | 221,969 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 12.04 per share. | 11 May 2021 | 102,780 | 110,275 (0%) | 0% | 12.0 | 1,237,471 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. | 11 May 2021 | 68,000 | 213,055 (0%) | 0% | 5.5 | 370,600 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 68,000 | 0 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 35,852 | 0 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.73 per share. | 11 May 2021 | 35,852 | 146,127 (0%) | 0% | 4.7 | 169,580 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.42 per share. | 11 May 2021 | 33,132 | 145,055 (0%) | 0% | 1.4 | 47,047 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 33,132 | 0 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 1,648 | 35,852 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.73 per share. | 11 May 2021 | 1,648 | 111,923 (0%) | 0% | 4.7 | 7,795 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Senior VP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 280,000 | 280,000 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Senior VP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.96 per share. | 11 Dec 2020 | 13,741 | 108,061 (0%) | 0% | 8.0 | 109,378 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Senior VP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2020 | 13,741 | 0 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Senior VP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.15 per share. | 11 Dec 2020 | 13,741 | 121,802 (0%) | 0% | 4.1 | 57,025 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Senior VP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 6.23 per share. | 04 Dec 2020 | 13,741 | 108,061 (0%) | 0% | 6.2 | 85,606 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Senior VP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Dec 2020 | 13,741 | 13,741 | - | - | Emp. Stock Option (Right to Buy) | |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Senior VP, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.15 per share. | 04 Dec 2020 | 13,741 | 121,802 (0%) | 0% | 4.1 | 57,025 | Common Stock |
| Biocryst Pharmaceuticals Inc. | Alane Barnes | Senior VP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2020 | 17,000 | 17,000 | - | - | Emp. Stock Option (Right to Buy) |